Center for Personalized Diagnostics - Precision Diagnostics

David Roth, MD, PhD, describes the legacy and mission of the Center for Personalized Diagnostics (CPD), a joint effort of Penn Medicine and the Abramson Cancer Center. Dr. Roth’s focus includes the collaborative efforts between oncologists and pathologists at the CPD and the techniques and prognostic benefits of gene panel diagnostics.

Related Links

• View Clinical Briefing: Personalized Diagnostics for Hematologic and Solid Tumor Cancers
• View Case Study: A 43-year-old man with IV non-small cell lung cancer identified with the tyrosine kinase mutation EML4-ALK.
• View Dr Roth's Profile